The Pharmacy Times® Immunization resource center provides the latest news in immunization. Here, you’ll find information about upcoming conferences and meetings, updated clinical trial listings, and other resources for those interested in vaccination.
Pharmacy Times®interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on Walgreens’ plans to provide access to COVID-19 vaccines among vulnerable populations in medically underserved communities.
The recommendations focus on dilution errors, vaccine and monoclonal antibody mix-ups, waste of doses, administering immunizations to the wrong age group, errors with scheduling the second dose, and allergic reactions.
Pharmacy Times®interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on whether any unforeseen problems have arisen during the first wave of COVID-19 vaccinations at long-term care facilities.
Pharmacy Times®interviewed Rina Shah, PharmD, group vice president of pharmacy operations and services at Walgreens, on the first wave of COVID-19 vaccine administration at long-term care facilities across the country.
A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.
Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.
Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.
The Pharmacy Times® Immunization resource center acts as a hub for all the latest clinical information pertaining to vaccines, with articles covering live-attenuated vaccines; inactivated vaccines; subunit, recombinant, polysaccharide; and conjugate vaccines. Here, pharmacists will find content surrounding the data from all phases of clinical trials and studies in the immunization, and information and coverage straight from the floor of from the ongoing conferences and annual meetings.